MarketPeel
Insider Trading Intelligence
JC

Jurgi Camblong

SOPH
CHIEF EXECUTIVE OFFICER · SOPHIA GENETICS SA · CIK 0002007050
FILING MIX · LIFETIME20%/80%
BUYS
7
SELLS
28
TOTAL VALUE
$1.95M
COMPANIES
1
ACTIVE SINCE
Mar 2026
HOLDINGS NOW
3,532,622
AVG SELL PX
$5.46
TRADE KIND
SHOWING 35 / 35
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
12 backtested trades · 8 horizons · 38 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Jurgi Camblong, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d12+33.33%+3.15%+2.55%+0.60%+0.18%
14d12+0.00%+3.08%+3.91%-0.73%-1.68%
30d12+33.33%+1.32%+7.82%-5.59%-6.89%
60d12+22.22%+3.28%+8.48%-5.13%-6.62%
90d12(2 pending)+0.00%+11.71%+10.60%+1.11%+4.72%
180d12(12 pending)
1y12(12 pending)
2y12(12 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
SOPH · 3,532,622 shares · as of Jul 10, 2026
0933,5131,867,0252,800,5383,734,050SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2026
2026
2026
FLOW · 7 buys / 28 sellsCOVERAGE · 3 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
8,500$5.62$47.8K3,532,622Jul 10, 2026Jul 14, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
17,685$5.28$93.3K3,541,122Jul 7, 2026Jul 8, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
22,486$5.26$118.2K3,558,807Jul 6, 2026Jul 7, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
45,419$6.14$279.0K3,601,143Jun 30, 2026Jul 1, 2026View →
SOPH
SOPHIA GENETICS SA
SALE
Executive Chairman
45,4194,581Jun 30, 2026Jul 1, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
200$6.30$1.3K3,581,293Jun 30, 2026Jul 1, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
19,650$6.02$118.3K3,581,493Jun 30, 2026Jul 1, 2026View →
SOPH
SOPHIA GENETICS SA
PURCHASE
Executive Chairman
45,419$3.16$143.5K3,646,562Jun 30, 2026Jul 1, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
350$6.00$2.1K3,601,143Jun 29, 2026Jul 1, 2026View →
SOPH
SOPHIA GENETICS SA
PURCHASE
Executive Chairman
18,060$3.16$57.1K3,619,553Jun 29, 2026Jul 1, 2026View →
SOPH
SOPHIA GENETICS SA
SALE
Executive Chairman
18,06050,000Jun 29, 2026Jul 1, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
18,060$5.87$106.0K3,601,493Jun 29, 2026Jul 1, 2026View →
SOPH
SOPHIA GENETICS SA
SALE
Chief Executive Officer
31,94068,060Jun 26, 2026Jun 29, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
31,940$5.84$186.4K3,601,493Jun 26, 2026Jun 29, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
18,129$5.73$103.9K3,601,493Jun 26, 2026Jun 29, 2026View →
SOPH
SOPHIA GENETICS SA
PURCHASE
Chief Executive Officer
31,940$3.16$100.9K3,633,433Jun 26, 2026Jun 29, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
1,373$5.70$7.8K3,619,622Jun 25, 2026Jun 29, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
8,500$5.24$44.5K3,620,995Jun 10, 2026Jun 11, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
4,486$4.60$20.7K3,629,495May 19, 2026May 20, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
8,500$5.09$43.2K3,633,981May 11, 2026May 12, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
4,486$5.21$23.3K3,642,481Apr 20, 2026Apr 21, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
17,473$5.00$87.4K3,646,967Apr 15, 2026Apr 16, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
43,129$4.96$213.8K3,664,440Apr 14, 2026Apr 16, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
4,399$4.76$21.0K3,707,569Apr 13, 2026Apr 14, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
8,500$4.72$40.1K3,715,700Apr 10, 2026Apr 14, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
3,732$4.72$17.6K3,711,968Apr 10, 2026Apr 14, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
1,950$4.74$9.2K3,724,200Apr 9, 2026Apr 10, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
2,800$4.84$13.6K3,726,150Apr 8, 2026Apr 10, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
2,500$4.86$12.2K3,728,950Apr 7, 2026Apr 8, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
2,600$4.85$12.6K3,731,450Apr 6, 2026Apr 8, 2026View →
SOPH
SOPHIA GENETICS SA
PURCHASEGRANT
Stock grant
628,743628,743Apr 2, 2026Apr 3, 2026View →
SOPH
SOPHIA GENETICS SA
PURCHASEGRANT
Stock grant
431,211431,211Apr 2, 2026Apr 3, 2026View →
SOPH
SOPHIA GENETICS SA
PURCHASEGRANT
Stock grant
431,2113,734,050Apr 2, 2026Apr 8, 2026View →
SOPH
SOPHIA GENETICS SA
PURCHASEGRANT
Stock grant
628,743628,743Apr 2, 2026Apr 8, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
4,486$4.77$21.4K3,302,839Mar 19, 2026Mar 20, 2026View →
Other insiders · SOPH
Loading peer insiders…
About this filer
CIK 0002007050
ROLE
Chief Executive Officer
PRIMARY
SOPH
COMPANIES
1
ACTIVE SINCE
Mar 2026
MARKETPEEL · /INSIDER/0002007050DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback